CXCL13 and head and neck squamous cell carcinoma: Furthermore, survival analysis using in 517 cases of head and neck squamous cell carcinomas showed that patients with higher CXCL13 expressions were associated with better overall survival (p = 0.0032) (Fig. 1C).